Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 59, 1999 - Issue 2
Submit an article Journal homepage
64
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate

M. A. Mansoor Department of Clinical Chemistry
,
O. Kristensen Department of Clinical Chemistry
,
T. Hervig Blood Bank, Central Hospital in Rogaland, Stavanger, Norway and
,
C. J. Bates MRC Human Nutrition Research, Cambridge, UK
,
K. Pentieva Department of Clinical Chemistry
,
H. Vefring Department of Clinical Chemistry
,
A. Osland Department of Clinical Chemistry
,
T. Berge Medical Department Elf Petroleum Stavanger, Norway;
,
P. A. Drabløs Norsk Hydro Karmuy, Norway,
,
ø. Hetland Department of Clinical Chemistry
&
S. Rolfsen Medical Department Elf Petroleum Stavanger, Norway;
 show all
Pages 139-146 | Published online: 08 Jul 2009

  • Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–57.
  • Bakker RC, Brandjes DPM. Hyperhomocysteine-mia and associated disease. Pharm World Sci 1997; 19: 126–32.
  • Malinow MR. Plasma homocyst(e)ine and arterial occlusive diseases: a mini review. Clin Chem 1994; 40: 173–6.
  • Moghadasian MH, Mcmanus BM, Frohlich JJ. Homocyst(e)ine and coronary disease. Clinical evidence and genetic and metabolic evidence. Arch Intern Med 1997; 157: 2299–308.
  • Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RBJ, editor. Atherosclerotic cardiovascu-lar disease, hemostasis, and endothelial function. New York: Marcel Dekker, 1992: 183–236.
  • Finkelstein JD. Methionine metabolism in mam-mals. J Nutr Biochem 1990; 1: 228–37.
  • Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem. 1984; 259: 9508— 13.
  • Brody T. Nutritional biochemistry. California: Academic Press, 1994
  • Carson NAJ, Carre U. Treatment of homocysti-nuria with pyridoxine: a preliminary study. Arch Dis Child 1969; 44: 387–92.
  • Barber GW, Spaeth GL. The successful treatment of homocystinuria with pyridoxine. J Pediatr 1969; 75: 463–78.
  • Freyburger G, Labrouche S, Sasoust G, Rouane F, Javorschi S, Parrot F. Mild hyperhomocystei-nemia and hemostatic factors in patients with arterial vascular disease. Thromb Haemost 1997; 77: 466–71.
  • Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattstrom L. Plasma homo-cysteine in acute myocardial infarction: homo-cysteine-lowering effect of folic acid. J Intern Med 1995; 237: 381–8.
  • Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, Bendich A, Selhub J, Rosenberg IH. High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 1996; 49: 147–52.
  • Mansoor MA, Svardal AM, Ueland PM. Deter-mination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma. Anal Biochem. 1992; 200: 218–29.
  • Bates C, Pentieva K, Matthews N, Macdonald A. A simple, sensitive and reproducible assay for pyridoxal phosphate and pyridoxic acid in human plasma. Clin Chim Acta 1999; in press
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
  • Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995; 10: 111–13.
  • Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC. Treatment of mild hyper-homocysteinemia in vascular disease patients. Arterioscler Thromb 1994; 14: 465–70.
  • Franken DG, Boers GHJ, Blom HJ, Trijbels JMF. Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocysteinemia in vascular patients. J Inher Metab Dis 1994; 17: 159–62.
  • Arnadottir M, Brattström L, Simonsen 0, Thysell H, Hultberg B, Andersson A, Nilsson EP. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993; 40: 236–40.
  • Arnadottir M, Hultberg B. Treatment with high-dose folic acid effectively lowers plasma homo- cysteine concentration in cyclosporine-treated renal transplant recipients. Transplantation 1997; 64: 1087.
  • Ward M, McNulty H, Mcpartlin J, Strain JJ, Weir DG, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physio-logical doses of folic acid. Q J Med 1997; 90: 519–24.
  • Dierkes J, Kroesen M, Pietrzik K. Folic acid and vitamin B6 supplementation and plasma homo-cysteine concentrations in healthy young women. Intern J Vit Nutr Res 1996; 68: 98–103.
  • Guttormsen AB, Ueland PM, Nesthus I, NyOrd 0, Schneede J, Vollset SE, Refsum H. Determina-tion and vitamin responsiveness of intermediate hyperhomocysteinemiaµmoliliter). TheHordaland Homocysteine Study. J Clin Invest 1996; 98: 2174–83.
  • Lucock MD, Wild J, Smithells RW, Hartley R. In vivo characterization of the absorption and biotransformation of pteroylmonoglutamic acid in man. A model for future studies. Biomed Med Metabol Biol 1989; 42: 30–42.
  • Lucock MD, Wild J, Smithells R, Hartley R. Biotransformation of pteroylmonoglutamic acid during absorption: implications of Michaelis—Menten kinetics. Euro J Clin Nutr 1989; 43: 631 — 5.
  • Clark S. Oral folic acid tolerance test in normal human subjects and patients with pernicious anemia. Proc Soc Exp Bio Med 1958; 82: 25–8.
  • Chanarin I. The megaloblastic anemias. London: Blackwell, 1979
  • Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997; 65: 1790–5.
  • Malinow MR, Nieto FJ, Kruger WD, Due11 PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotype. Arterioscler Thromb Vasc Biol 1997; 17: 1157–62.
  • Ubbink JB, Merwe Avd, Delport R, Allen RH, Stabler SP, Riezler R, Vermaak WJ. The effect of a subnormal vitamin B6-status on homocysteine metabolism. J Clin Invest 1996; 98: 177–84.
  • Ubbink JB, Vermaak WJH, Merwe Avd, Becker PJ, Delport R, Potgier HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994; 124: 1927–33.
  • Morrow GI, Barness LA. Combined vitamin responsiveness in homocystinuria. J Pediatr 1972; 81: 946 — 54.
  • Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ. Sensory neuropathy from pyridoxine abuse. A new mega-vitamin syndrome. N Engl J Med 1983; 309: 445–8.
  • Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology 1985; 35: 1466–8.
  • Brattstr6m L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B, Hamfelt A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease—effects of pyridoxine and folic acid treatment. Atherosclero-sis 1990; 81: 51–60.
  • Chauveau P, Chadefaux B, Coudé M, Aupetit J, Kamoun P, Jungers P. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab 1996; 22: 106–9.
  • Speitling A, Heseker H, Kilbler W. Adaptation effects in humans to chronic high vitamin B6 supplementation. New York: Alan R Liss Inc, 1988
  • Mansoor MA, Bergmark C, Svardal AM, Lonning PE, Ueland PM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular dis-ease. Arterioscler Thromb Vasc Biol 1995; 15: 232–40.
  • Bergmark C, Mansoor MA, Swedenborg JFair Ud, Svardal AM, Ueland PM. Hyperhomocystei-nemia in patients operated for lower extremity ischaemia below the age of 50—effect of smoking and extent of disease. Eur J Vasc Surg 1993; 7: 391–6.
  • Nygard 0, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995; 274: 1526–33.
  • Bates C, Mansoor MA, Pols Jvd, Prentice A, Cole T, Finch S. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur J Clin Nutr 1997; 51: 691–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.